Save up to 84% on brand name Sprycel and over 95% with the generic Sprycel.
Click here for information on Zydus generics (Immediate availability)
For brand name Sprycel, Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.
According to the European Medicines Agency, brand name Sprycel originating from Europe is manufactured at the following site(s):Swords Laboratories Unlimited Company T/A Lawrence Laboratories
Unit 12 & 15, Distribution Centre
Shannon Industrial Estate
Shannon, Co. Clare, V14 DD39
Ireland
Information about Sprycel (Dasatinib)
Sprycel is a prescription medication that contains dasatinib as its active ingredient. It is primarily used in the treatment of certain types of cancer, specifically chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). Dasatinib is a tyrosine kinase inhibitor, which works by blocking the action of abnormal proteins that promote the growth of cancer cells.
Product Highlights
- Particularly in patients with Philadelphia chromosome-positive (Ph+) CML.
- For patients with Philadelphia chromosome-positive (Ph+) ALL, especially in cases that are resistant or intolerant to prior therapies.
- Occasionally, Sprycel is used for treatment in certain cases of leukemia that have relapsed or are resistant to other treatments.
Key Ingredient
Key Benefits
- Sprycel has shown to be effective in controlling chronic and acute leukemia, particularly in patients with the Philadelphia chromosome.
- It selectively targets abnormal proteins that promote cancer growth, helping to minimize damage to normal cells.
- Sprycel is taken orally, providing ease of use compared to intravenous therapies.
- Sprycel is beneficial for patients who have developed resistance or intolerance to first-line leukemia treatments, offering an alternative option.
Direction of Use
- The dosage depends on the specific condition being treated and the patient's response to the therapy. For example:
- Typically, 100 mg once daily for chronic phase, with possible dose adjustments based on response and tolerance.
- Often 140 mg once daily, but this can vary.
- Take Sprycel tablets once daily, with or without food, at the same time each day. Swallow the tablets whole with water; do not break, crush, or chew them.
- Dosage may be adjusted based on side effects, laboratory tests, and clinical response. Regular monitoring is essential to determine appropriate adjustments.
Safety Concerns
- Dasatinib can cause serious heart problems, including fluid retention, heart failure, and other cardiovascular complications.
- It can lower the number of blood cells, leading to risks of infection, bleeding, and anemia. Ongoing blood tests are required to monitor this.
- Dasatinib can lead to severe lung issues, such as pleural effusion (fluid accumulation around the lungs).
- Increased risk of bleeding or bruising.
- Liver toxicity is a potential concern, requiring monitoring of liver function during treatment.
- Nausea, vomiting, and diarrhea are common, and may lead to dehydration if severe.
- Sprycel interacts with a variety of other medications, so a detailed list of any current medications should be shared with your healthcare provider to avoid dangerous interactions.
Avoid Sprycel (Dasatinib) If
- Dasatinib can cause harm to a developing fetus and should be avoided during pregnancy. It is also not recommended during breastfeeding.
- If you have severe hepatic impairment, Sprycel should not be used.
- Due to its potential to cause fluid retention and heart failure, Sprycel should be avoided in patients with severe cardiovascular disease.
- Dasatinib may increase the risk of bleeding or bruising, and should be avoided if you have a history of bleeding disorders.
- Any known hypersensitivity to the drug or its components should lead to avoiding its use.
